Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Long-Term Deferred Tax (2017)

Historic Long-Term Deferred Tax for RedHill Biopharma (RDHL) over the last 1 years, with Q4 2017 value amounting to $76.0 million.

  • RedHill Biopharma's Long-Term Deferred Tax changed N/A to $76.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $76.0 million, marking a year-over-year change of. This contributed to the annual value of $76.0 million for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q4 2017, RedHill Biopharma's Long-Term Deferred Tax is $76.0 million.
  • RedHill Biopharma's 5-year Long-Term Deferred Tax high stood at $76.0 million for Q4 2017, and its period low was $76.0 million during Q4 2017.